{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:08:18Z","timestamp":1793714898324,"version":"4.6.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:p>\n                    The mortality rate related to variceal bleeding is high in patients with liver cirrhosis. Early detection and treatment of varices can reduce the risk of hemorrhage and thus decrease the mortality rate related to variceal bleeding. The study comprised 81 cirrhotic patients in training set, who were categorized into 2 groups: the patients with esophageal varices (EVs group) and the patients without esophageal varices (non-EVs group). The disparity in Cystatin C\/albumin ratio (CAR) was assessed between these 2 groups. Subsequently, a regression model was constructed by generating a receiver operating characteristic (ROC) curve to calculate the area under the curve (AUC). Then an external validation was performed in 25 patients. Among patients with cirrhosis in training set, a statistically significant difference in CAR was observed between the EVs group and non-EVs group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). At the CAR cutoff value of 2.79*10\n                    <jats:sup>\u22125<\/jats:sup>\n                    , the AUC for diagnosing EVs were 0.666. Further, a multivariate logistic regression model was constructed, after adjusting the model, the AUC for EVs diagnosis were 0.855. And the external validation showed that the model could not be considered as a poor fit. CAR exhibits potential as an early detection marker for EVs in liver cirrhosis, and the regression model incorporating CAR demonstrates a strong capability for early EVs diagnosis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038481","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:47:21Z","timestamp":1719586041000},"page":"e38481","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cystatin C\/albumin ratio for early diagnosis of esophageal varices in liver cirrhosis"],"prefix":"10.1097","volume":"103","author":[{"given":"Hui","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China"},{"name":"Department of Gastroenterology, the Second Affiliated Hospital of Dalian Medical University, Dalian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-7974","authenticated-orcid":false,"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260223","first-page":"759","article-title":"Cirrhosis: diagnosis and management.","volume":"100","author":"Smith","year":"2019","journal-title":"Am Fam Physician"},{"key":"R2-20260223","doi-asserted-by":"crossref","first-page":"59","DOI":"10.21315\/mjms2019.26.2.7","article-title":"Serum ferritin levels: a potential biomarker to represent child-turcotte-pugh score among decompensated liver cirrhosis patients.","volume":"26","author":"Sungkar","year":"2019","journal-title":"Malays J Med Sci"},{"key":"R3-20260223","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"R4-20260223","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","article-title":"Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database.","volume":"65","author":"Kovalak","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R5-20260223","first-page":"1029","article-title":"Guidelines on the management of esophagogastric variceal bleeding in cirrhotic portal hypertension.","volume":"30","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R6-20260223","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","article-title":"Improving prognosis following a first variceal haemorrhage over four decades.","volume":"49","author":"McCormick","year":"2001","journal-title":"Gut"},{"key":"R7-20260223","first-page":"63","article-title":"Cystatin C-properties and use as diagnostic marker.","volume":"35","author":"Grubb","year":"2000","journal-title":"Adv Clin Chem"},{"key":"R8-20260223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR-history, indications, and future research.","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem"},{"key":"R9-20260223","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cccn.2003.11.011","article-title":"Increased cystatin C serum concentrations in patients with hepatic diseases of various severities.","volume":"341","author":"Chu","year":"2004","journal-title":"Clin Chim Acta"},{"key":"R10-20260223","first-page":"3","article-title":"Correlation between high serum cystatin C and liver function in patients with cirrhosis.","volume":"23","author":"Xue","year":"2011","journal-title":"Western Medicine"},{"key":"R11-20260223","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00042737-200108000-00013","article-title":"Elevation of serum cystatin C concentrations in patients with chronic liver disease.","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R12-20260223","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jgh.13492","article-title":"Neutrophil gelatinase-associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.","volume":"32","author":"Hurry","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"R13-20260223","doi-asserted-by":"crossref","DOI":"10.3390\/medicina54030037","article-title":"The clinical importance of cystatin c and hepatic artery resistive index in liver cirrhosis.","author":"Stulic","year":"2018","journal-title":"Medicina (Kaunas)"},{"key":"R14-20260223","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jgh.15306","article-title":"Development and validation of a radiomics signature as a non-invasive complementary predictor of gastroesophageal varices and high-risk varices in compensated advanced chronic liver disease: a multicenter study.","volume":"36","author":"Huang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R15-20260223","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients.","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"R16-20260223","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.","volume":"319","author":"Brocchi","year":"1988","journal-title":"N Engl J Med"},{"key":"R17-20260223","doi-asserted-by":"crossref","first-page":"298","DOI":"10.31729\/jnma.3202","article-title":"Non-invasive predictors of gastro-oesophageal varices.","volume":"56","author":"Bhattarai","year":"2017","journal-title":"JNMA J Nepal Med Assoc"},{"key":"R18-20260223","doi-asserted-by":"crossref","first-page":"412","DOI":"10.31729\/jnma.3379","article-title":"Significance of non-invasive markers as predictor of esophageal varices in liver cirrhosis.","volume":"56","author":"Khadka","year":"2017","journal-title":"JNMA J Nepal Med Assoc"},{"key":"R19-20260223","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.5152\/tjg.2019.18334","article-title":"Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India.","volume":"30","author":"Kothari","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"R20-20260223","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clinbiochem.2005.03.005","article-title":"Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease.","volume":"38","author":"Chen","year":"2005","journal-title":"Clin Biochem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:01:59Z","timestamp":1771884119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":20,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038481","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}